An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects
Latest Information Update: 19 Mar 2020
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Axial spondyloarthritis; Juvenile rheumatoid arthritis; Non-radiographic axial spondyloarthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis
- Focus Pharmacokinetics
- 19 Mar 2020 New trial record
- 14 Mar 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics